CVE-2019-12292
CVE-2019-12292 is a critical-severity vulnerability in Citrix Appdna with a CVSS 3.x base score of 9.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low.
Key facts
- Severity: Critical (CVSS 3.x base score 9.8)
- CVSS v2: 7.5
- EPSS exploit prediction: 1% (71st percentile)
- Actively exploited: Not listed in CISA KEV
- Affected product: Citrix Appdna
- Published:
- Last modified:
Description
Citrix AppDNA before 7 1906.1.0.472 has Incorrect Access Control.
Frequently asked questions
- What is CVE-2019-12292?
- Citrix AppDNA before 7 1906.1.0.472 has Incorrect Access Control.
- How severe is CVE-2019-12292?
- CVE-2019-12292 has a CVSS 3.x base score of 9.8, rated critical severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
- Is CVE-2019-12292 being actively exploited?
- It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (71st percentile), an estimate of the probability of exploitation in the next 30 days.
- What products are affected by CVE-2019-12292?
- CVE-2019-12292 affects Citrix Appdna. See the affected-products list for the exact vulnerable versions.
- How do I fix CVE-2019-12292?
- Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.
- When was CVE-2019-12292 published?
- CVE-2019-12292 was published on 2019-06-24 and last updated on 2026-06-17.
References
- https://support.citrix.com/article/CTX253828
- https://support.citrix.com/search?searchQuery=%2A&lang=en&sort=relevance&prod=&pver=&ct=Security+Bulletin
Affected products (1)
- cpe:2.3:a:citrix:appdna:*:*:*:*:*:*:*:*